Comparative cardiovascular effectiveness of glucagon-like peptide-1 receptor agonists versus sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: A population-based cohort study
Journal
Diabetes, obesity & metabolism
Journal Volume
24
Journal Issue
8
Pages
1623
Date Issued
2022
Author(s)
Abstract
To examine the comparative effectiveness of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 (SGLT2) inhibitors for select cardiovascular outcomes and to examine whether the relative risks varied across different patient subgroups in patients with type 2 diabetes.
Subjects
cardiovascular disease; chronic kidney disease; cohort study; glucagon-like peptide-1 receptor agonists (GLP-1RAs); haemorrhagic stroke; heart failure; ischaemic stroke; myocardial infarction; sodium glucose cotransporter-2 (SGLT2); stroke; type 2 diabetes
SDGs
Publisher
WILEY
Type
journal article
